These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20622048)

  • 21. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
    Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
    J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses.
    Altman JK; Yoon P; Katsoulidis E; Kroczynska B; Sassano A; Redig AJ; Glaser H; Jordan A; Tallman MS; Hay N; Platanias LC
    J Biol Chem; 2008 Jan; 283(4):1992-2001. PubMed ID: 18048359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptomic analysis of the PI3K/Akt signaling pathway reveals the dual role of the c-Jun oncogene in cytotoxicity and the development of resistance in HL-60 leukemia cells in response to arsenic trioxide.
    Roszak J; Smok-Pieniążek A; Stępnik M
    Adv Clin Exp Med; 2017 Dec; 26(9):1335-1342. PubMed ID: 29442453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24.
    Cao Y; Yu SL; Wang Y; Guo GY; Ding Q; An RH
    Tumour Biol; 2011 Feb; 32(1):179-88. PubMed ID: 20857258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide.
    Amigo-Jiménez I; Bailón E; Ugarte-Berzal E; Aguilera-Montilla N; García-Marco JA; García-Pardo A
    PLoS One; 2014; 9(6):e99993. PubMed ID: 24956101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway.
    Bornhauser BC; Bonapace L; Lindholm D; Martinez R; Cario G; Schrappe M; Niggli FK; Schäfer BW; Bourquin JP
    Blood; 2007 Sep; 110(6):2084-91. PubMed ID: 17537996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arsenic trioxide and radiation enhance apoptotic effects in HL-60 cells through increased ROS generation and regulation of JNK and p38 MAPK signaling pathways.
    Ho SY; Wu WJ; Chiu HW; Chen YA; Ho YS; Guo HR; Wang YJ
    Chem Biol Interact; 2011 Sep; 193(2):162-71. PubMed ID: 21741957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arsenic trioxide overcomes rapamycin-induced feedback activation of AKT and ERK signaling to enhance the anti-tumor effects in breast cancer.
    Guilbert C; Annis MG; Dong Z; Siegel PM; Miller WH; Mann KK
    PLoS One; 2013; 8(12):e85995. PubMed ID: 24392034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
    Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P
    Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
    Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
    J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenic trioxide decreases AKT protein in a caspase-dependent manner.
    Mann KK; Colombo M; Miller WH
    Mol Cancer Ther; 2008 Jun; 7(6):1680-7. PubMed ID: 18566239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms.
    Zhang W; Ohnishi K; Shigeno K; Fujisawa S; Naito K; Nakamura S; Takeshita K; Takeshita A; Ohno R
    Leukemia; 1998 Sep; 12(9):1383-91. PubMed ID: 9737686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C.
    Pelicano H; Carew JS; McQueen TJ; Andreeff M; Plunkett W; Keating MJ; Huang P
    Leukemia; 2006 Apr; 20(4):610-9. PubMed ID: 16482209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative inactivation of the lipid phosphatase phosphatase and tensin homolog on chromosome ten (PTEN) as a novel mechanism of acquired long QT syndrome.
    Wan X; Dennis AT; Obejero-Paz C; Overholt JL; Heredia-Moya J; Kirk KL; Ficker E
    J Biol Chem; 2011 Jan; 286(4):2843-52. PubMed ID: 21097842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indomethacin-enhanced anticancer effect of arsenic trioxide in A549 cell line: involvement of apoptosis and phospho-ERK and p38 MAPK pathways.
    Mandegary A; Torshabi M; Seyedabadi M; Amirheidari B; Sharif E; Ghahremani MH
    Biomed Res Int; 2013; 2013():237543. PubMed ID: 24312908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel human neutrophil agonistic properties of arsenic trioxide: involvement of p38 mitogen-activated protein kinase and/or c-jun NH2-terminal MAPK but not extracellular signal-regulated kinases-1/2.
    Binet F; Girard D
    J Leukoc Biol; 2008 Dec; 84(6):1613-22. PubMed ID: 18728151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenic trioxide-induced apoptosis in U937 cells involve generation of reactive oxygen species and inhibition of Akt.
    Choi YJ; Park JW; Suh SI; Mun KC; Bae JH; Song DK; Kim SP; Kwon TK
    Int J Oncol; 2002 Sep; 21(3):603-10. PubMed ID: 12168106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM; Tseng JT; Hong DY; Huang HS
    Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
    Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
    J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.
    Biswas S; Zhao X; Mone AP; Mo X; Vargo M; Jarjoura D; Byrd JC; Muthusamy N
    Leuk Res; 2010 Jul; 34(7):925-31. PubMed ID: 20171736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.